When a new Medicare Part D enrollee’s medication is not on the plan formulary
A new Medicare Part D enrollee can run into trouble at the pharmacy counter. The person arrives for a medication they were already taking, only to learn that the new plan does not list it on its formulary or covers it only after requirements have been met. That is where a transition fill comes in.
The basic purpose is temporary continuity. A transition fill gives the enrollee a short-term way to obtain a current medication while the coverage problem is addressed. It is not the same as full formulary coverage, and it does not determine whether the plan will continue paying for the drug. It creates time for the enrollee, prescriber, and plan to decide what happens next.
Per CMS, Medicare Part D coverage comes through private plans approved by Medicare. Those plans use formularies and cost-sharing structures that differ from one plan to another. As a result, someone can switch into a plan with different formulary rules even though the medication itself has not changed.
The purpose of a transition fill
In practical terms, a transition fill is a temporary supply of a drug that a new enrollee is already taking when the drug is not on the plan formulary or is subject to utilization management that has not yet been satisfied. The pharmacy processes the claim under the plan’s transition process rather than its standard ongoing coverage rules.
This is a bridge, not a guarantee. During that period, the prescriber can switch the patient to a formulary alternative, request a formulary exception, or work with the plan to satisfy prior authorization or another coverage requirement for the existing drug. If none of those routes succeeds, the temporary supply can end without ongoing coverage.
That distinction matters. A medication dispensed under a transition policy is not necessarily on the formulary. The plan is allowing temporary access while the enrollee completes the administrative step that follows.
Why the plan does not list a medication for ordinary coverage
A formulary is the plan’s list of covered drugs. CMS explains that Part D plans use formularies and that those lists differ among plans. A medication can be unavailable for ongoing coverage because it is excluded entirely, listed only in another form or strength, or subject to prior authorization, step therapy, or another requirement. The plan can also prefer other products in the same class.
So “not covered” at the pharmacy counter does not always describe the same problem. The drug might be fully non-formulary. Or it might be coverable after the plan receives additional information.
Recent formulary behavior for certain products illustrates how selective Part D coverage can be. Drug Channels reported that a recent JAMA Network Open study identified 12 ustekinumab products available for formulary coverage in early 2026, while plan coverage remained limited and uneven. That variation helps explain why a medication available under one arrangement is not readily covered under another.
What to do when the pharmacy rejects the claim
The pharmacy is often where the problem first appears, but resolving it usually takes coordination beyond the counter. The enrollee should ask whether the rejection resulted from the drug being non-formulary, a prior authorization requirement, or another coverage rule. Each one points to a different next step.
Usually, the process moves in one of three directions:
- The prescriber changes the prescription to a formulary alternative.
- The prescriber asks the plan for an exception or submits the required coverage documentation.
- The enrollee requests a coverage determination and, if needed, continues into the appeal process.
A transition fill gives everyone time to do that work. It does not take its place.
How to use the bridge period
Patients should view a transition fill as a warning flag rather than a final coverage decision. If the current medication is clinically necessary, the prescriber needs to explain why covered alternatives are not appropriate. When the medication can be switched safely, a formulary alternative can resolve the issue faster than an exception request.
Pharmacists also need to separate temporary access from lasting coverage. A paid transition claim can prevent an immediate gap in therapy, but it signals that follow-up remains necessary. The pharmacist can often identify whether the claim is non-formulary, subject to prior authorization, or blocked for another reason. That detail helps the prescriber submit the appropriate request.
Benefits managers and family caregivers should keep the plan-specific nature of Part D coverage in mind. CMS states that formularies and cost-sharing structures vary by plan. Transition issues therefore often reflect plan design rather than pharmacy error. The practical question is whether the enrollee can move from temporary access to an approved long-term pathway.
Paying for medication during a transition fill
A transition fill still runs through the enrollee’s Part D plan, so the enrollee can owe the plan’s applicable cost sharing for that temporary supply. CMS also says that people with limited income and resources can qualify for Extra Help, also called the Part D Low-Income Subsidy, which lowers Part D costs. Medicare.gov similarly states that Extra Help assists qualifying people with premiums, deductibles, and copayments.
That support can matter when the enrollee faces repeated pharmacy trips while the coverage issue remains unresolved. For people who qualify, checking Extra Help eligibility belongs in the practical response.
Another point causes confusion. CMS states that manufacturer copay coupons generally cannot be used with federal health care programs such as Medicare because of federal anti-kickback restrictions. A coupon that worked before Medicare enrollment therefore is not necessarily available as a fallback.
When the temporary supply ends
The best outcome is not simply receiving the first temporary fill. The goal is a stable next step: continued coverage of the existing medication through an approved exception or authorization, or a switch to a formulary drug the prescriber considers appropriate.
For a new enrollee, that is the practical rule. A transition fill helps prevent an abrupt stop, then the plan, pharmacist, and prescribing clinician need to resolve the coverage question.
Disclaimer: This article is for general educational purposes only and is not medical, legal, or insurance advice. Medicare Part D coverage decisions are plan-specific. Patients should consult their plan documents, pharmacist, prescribing clinician, or Medicare for guidance on their individual situation.